Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study-Reference-Cited by-同舟云学术

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study

Published:2022-12 Issue: Volume:66 Page:85-88
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Yıldırım Hasan Çağrı^ORCID,Mutlu Emel,Chalabiyev Elvin^ORCID,Özen Miraç,Keskinkılıç Merve,Ön Sercan,Çelebi Abdussamet,Dursun Bengü,Acar Ömer,Kahraman Seda,Aykan Musa Barış,Kaman Ömür,Doğan Akif,Erdoğan Atike Pınar,Melisa Celayir Özde,Günenç Damla,Güven Deniz Can,Vedat Bayoğlu İbrahim,Yavuzşen Tuğba,Hacıbekiroğlu İlhan,İnanç Mevlüde,Kılıçkap Saadettin,Yalçın Şuayib,Aksoy Sercan

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference18 articles.

1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin Med J,2022

2. Incidence and outcome of male breast cancer: an international population-based study;Miao;J Clin Oncol,2011

3. Male breast cancer according to tumor subtype and race: a population‐based study;Chavez‐MacGregor;Cancer,2013

4. Breast cancer screening in high-risk men: a 12-year longitudinal observational study of male breast imaging utilization and outcomes;Gao;Radiology,2019

5. Fulvestrant and male breast cancer: a case series;Zagouri;Ann Oncol,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer;Geburtshilfe und Frauenheilkunde;2024-09

2. Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials;Oncology and Therapy;2024-08-02

3. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer;Medicine;2024-07-26

4. CDK4/6 inhibitors: The Devil is in the Detail;Current Oncology Reports;2024-05-07

5. Clinical characteristics and prognostic factors of male breast cancer in China;Frontiers in Oncology;2024-03-08